Changes in haemostatic and platelet activation markers in non-dipper hypertensive patients

Athanasia Agorasti1, Efthimia Mourvati, Theodoros Trivellas

  • 1Department of Haematology Laboratory, General Hospital of Xanthi, Ephessou 68, 67100 Xanthi, Greece. vhrissan@civil.duth.gr

Insights

Non-dipper hypertensive patients show higher levels of key blood clotting and fibrinolysis markers. These haemostatic alterations in non-dippers may contribute to their increased cardiovascular disease risk.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Hemostasis and Thrombosis

Background:

  • Non-dipper hypertension is a recognized risk factor for cardiovascular disease.
  • Activation of coagulation and fibrinolysis pathways are implicated in cardiovascular risk.
  • Understanding haemostatic differences in non-dippers is crucial for risk stratification.

Purpose of the Study:

  • To investigate the relationship between haemostatic and platelet activation markers and the non-dipping blood pressure pattern.
  • To compare coagulation and fibrinolysis markers in treated hypertensive patients with and without the non-dipping pattern.

Main Methods:

  • Seventy-one treated hypertensive patients were categorized as dippers or non-dippers based on 24-hour ambulatory blood pressure monitoring.
  • Plasma levels of coagulation factors (VIII, IX, fibrinogen), activation markers (prothrombin fragment 1+2, thrombin-antithrombin complex), and fibrinolysis markers (protein C, plasmin-alpha-2-antiplasmin complex, D-dimer) were measured.
  • Platelet factor 4 was also assessed as a marker of platelet activation.

Main Results:

  • Non-dipper hypertensive patients exhibited significantly higher plasma levels of factors VIII and IX, fibrinogen, prothrombin fragment 1+2, protein C, plasmin-alpha-2-antiplasmin complex, and D-dimers compared to dippers.
  • No significant differences were observed in thrombin-antithrombin complex or platelet factor 4 levels between the groups.
  • These findings indicate widespread alterations in haemostasis among non-dipper hypertensive individuals.

Conclusions:

  • Treated hypertensive patients with a non-dipping blood pressure pattern demonstrate significant alterations in haemostatic and fibrinolytic markers.
  • These haemostatic changes in non-dippers may contribute to their elevated risk of cardiovascular events.
  • Further research is warranted to explore therapeutic strategies targeting these haemostatic pathways in non-dipper hypertension.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...